Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin
文献类型：期刊论文
| 作者 | Xie XH; Wang XL; Zhang G; He YX; Leng Y; Tang TT; Pan X; Qin L |
| 刊名 | JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
 |
| 出版日期 | 2015 |
| 英文摘要 | A phytomolecule, icaritin, has been identified and shown to be osteopromotive for the prevention of osteoporosis and osteonecrosis. This study aimed to produce a bioactive poly (l-lactide-co-glycolide)-tricalcium phosphate (PLGA-TCP)-based porous scaffold incorporating the osteopromotive phytomoleculeicaritin, using a fine spinning technology. Both the structure and the composition of icaritin-releasing PLGA-TCP-based scaffolds were evaluated by scanning electron microscopy (SEM). The porosity was quantified by both water absorption and micro-computed tomography (micro-CT). The mechanical properties were evaluated using a compression test. In vitro release of icaritin from the PLGA-TCP scaffold was quantified by high-performance liquid chromatography (HPLC). The attachment, proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) on the composite scaffold were evaluated. Both an in vitro cytotoxicity test and an in vivo test via muscular implantation were conducted to confirm the scaffold's biocompatibility. The results showed that the PLGA-TCP-icaritin composite scaffold was porous, with interconnected macro- (about 480 mu m) and micropores (2-15 mu m). The mechanical properties of the PLGA-TCP-icaritin scaffold were comparable with those of the pure PLGA-TCP scaffold, yet was spinning direction-dependent. Icaritin content was detected in the medium and increased with time. The PLGA-TCP-icaritinscaffold facilitated the attachment, proliferation and osteogenic differentiation of BMSCs. In vitro cytotoxicity test and in vivo intramuscular implantation showed that the composite scaffold had no toxicity with good biocompatibility. In conclusion, an osteopromotive phytomolecule, icaritin, was successfully incorporated into PLGA-TCP to form an innovative porous composite scaffold with sustained release of osteopromotive icaritin, and this scaffold had good biocompatibility and osteopromotion, suggesting its potential for orthopaedic applications |
| 收录类别 | SCI |
| 原文出处 | http://www.ncbi.nlm.nih.gov/pubmed/23255530 |
| 语种 | 英语 |
| 源URL | [http://ir.siat.ac.cn:8080/handle/172644/7193]  |
| 专题 | 深圳先进技术研究院_医工所 |
| 作者单位 | JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE |
| 推荐引用方式 GB/T 7714 | Xie XH,Wang XL,Zhang G,et al. Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin[J]. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE,2015. |
| APA | Xie XH.,Wang XL.,Zhang G.,He YX.,Leng Y.,...&Qin L.(2015).Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin.JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. |
| MLA | Xie XH,et al."Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin".JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2015). |
入库方式： OAI收割
来源：深圳先进技术研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。